Georgy Pobelyanskiy
CEO
Anesthesiology
WERTEKS
Russian Federation
Biography
The Company was incorporated in late 1999 and then began a preparatory stage for obtaining a license for the production of medicines: development and registration of the products, organization of the production area, selection of qualified employees etc. In 2003, WERTEKS received the first license to produce medicines that became the starting point of entering the market as the pharmaceutical manufacturer and the key to its development. However, the most important project for WERTEKS during its existence became the construction of a full-cycle pharmaceutical plant in St. Petersburg, launched at the end of August 2015. This is the first stage of innovative industrial complex construction located on a land site in Novoorlovskaya territory of the special economic zone, naimed Saint-Petersburg. Of course, one of the main reasons to be proud is the construction of a large pharmaceutical plant in just two years – says CEO Georgy Pobelyanskiy. – For us, it is comparable to Neil Armstrong’s first landing on the moon. Paraphrasing his words, that’s one small step for mankind, one giant leap for WERTEKS. The plant occupy over 20 000 square meters. This is one of the largest pharmaceutical plants, not only in Russia but also in Europe. Investments in the project amounted to over 2.2 billion rubles. WERTEKS intends to use part of the new platform productive power for contract manufacturing.
Research Interest
pharma